Citation Impact
Citing Papers
Inhibition of vascular endothelial growth factor with a sequence-specific hypoxia response element antagonist
2004 StandoutNobel
Vascular Endothelial Growth Factor Receptor-1 Contributes to Resistance to Anti–Epidermal Growth Factor Receptor Drugs in Human Cancer Cells
2008
Organic Synthesis—Where now?
1990
Antitumor activity of HER-2 inhibitors
2004
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
PNA hybridizes to complementary oligonucleotides obeying the Watson–Crick hydrogen-bonding rules
1993 StandoutNature
Recent advances in the catalytic asymmetric synthesis of β-amino acids
2010 StandoutNobel
Asymmetric Counteranion‐Directed Catalysis for the Epoxidation of Enals
2007 StandoutNobel
Psoriasis
2009 Standout
Dynamic Covalent Chemistry
2002 StandoutNobel
Small-Molecule Inhibition of c-MYC:MAX Leucine Zipper Formation Is Revealed by Ion Mobility Mass Spectrometry
2012 StandoutNobel
Cell Signaling by Receptor Tyrosine Kinases
2010 Standout
Classifying Melanocytic Tumors Based on DNA Copy Number Changes
2003
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
2001 Standout
Inhibition of Protein Kinase CK2 by Anthraquinone-related Compounds
2003
GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects
2010 Standout
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Molybdenum and Tungsten Imido Alkylidene Complexes as Efficient Olefin‐Metathesis Catalysts
2003 StandoutNobel
Organocatalytic Enantioselective Decarboxylative Aldol Reaction of Malonic Acid Half Thioesters with Aldehydes
2013 StandoutNobel
Targeting the function of the HER2 oncogene in human cancer therapeutics
2007
Alkyne Metathesis: Development of a Novel Molybdenum-Based Catalyst System and Its Application to the Total Synthesis of Epothilone A and C
2001
pH-Sensitive Nanoparticles: An Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitors in Dogs
1996
Distinct Sets of Genetic Alterations in Melanoma
2005 Standout
Targeted Molecular Therapy of GBM
2003
Essential Role for Cathepsin S in MHC Class II–Associated Invariant Chain Processing and Peptide Loading
1996
Intrinsic Disorder in Cell-signaling and Cancer-associated Proteins
2002
CASK Functions as a Mg2+-Independent Neurexin Kinase
2008 StandoutNobel
β-Arrestin–mediated β1-adrenergic receptor transactivation of the EGFR confers cardioprotection
2007 StandoutNobel
Signalling from adenosine receptors to mitogen-activated protein kinases
2003
The advent and development of organocatalysis
2008 StandoutNature
Gold nanoparticle-based electrochemical detection of protein phosphorylation
2007
Lessons learned from the development of an Abl tyrosine kinase inhibitor for chronic myelogenous leukemia
2000
Towards High‐Performance Lewis Acid Organocatalysis
2014 StandoutNobel
Global, In Vivo, and Site-Specific Phosphorylation Dynamics in Signaling Networks
2006 Standout
Mitogen‐activated protein kinases interacting kinases are autoinhibited by a reprogrammed activation segment
2006
Bisphosphonate conjugation for bone specific drug targeting
2018
Engineering the third wave of biocatalysis
2012 StandoutNature
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Activation of H2O2 by Chiral Confined Brønsted Acids: A Highly Enantioselective Catalytic Sulfoxidation
2012 StandoutNobel
Stereocontrolled Synthesis of a Nonracemic Vitamin B12 A−B-Semicorrin
1997 StandoutNobel
Design and Synthesis of 5-Aryl-pyridone-carboxamides as Inhibitors of Anaplastic Lymphoma Kinase
2006
Catalytic Asymmetric Epoxidation of Cyclic Enones
2008 StandoutNobel
A short and efficient enantioselective route to a key intermediate for the total synthesis of forskolin
1989 StandoutNobel
Covalent Chemistry beyond Molecules
2016 StandoutNobel
A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor.
2001
Advances in Transition Metal (Pd,Ni,Fe)-Catalyzed Cross-Coupling Reactions Using Alkyl-organometallics as Reaction Partners
2011 Standout
The atom, the molecule, and the covalent organic framework
2017 StandoutScienceNobel
Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves
2010 StandoutNobel
Extremely Active Organocatalysts Enable a Highly Enantioselective Addition of Allyltrimethylsilane to Aldehydes
2016 StandoutNobel
Highly Diastereoselective 1,4-Addition of an Organocuprate to Methyl α-d -Gluco-, α-d -Manno-, or α-d -Galactopyranosides Tethering an α,β-Unsaturated Ester. Novel Asymmetric Access to β-C-Substituted Butanoic Acids
2001
TADDOLs, Their Derivatives, and TADDOL Analogues: Versatile Chiral Auxiliaries
2001
Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment
2018 StandoutNobel
Vitamin B12: Experiments Concerning the Origin of Its Molecular Structure
1988
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Rapid access to N -Boc phenylglycine derivatives via benzylic lithiation reactions
2001
The Smelling Principle of Vetiver Oil, Unveiled by Chemical Synthesis
2020 StandoutNobel
The Formation of Immunogenic Major Histocompatibility Complex Class II–Peptide Ligands in Lysosomal Compartments of Dendritic Cells Is Regulated by Inflammatory Stimuli
2000 StandoutNobel
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
The total synthesis of vitamin B12
1973
Limitations in the application of anionic oxy-cope sigmatropy to elaboration of the forskolin nucleus
1989
Differential phosphoprofiles of EGF and EGFR kinase inhibitor-treated human tumor cells and mouse xenografts
2004
Catalytic Asymmetric Conjugate Addition and Allylic Alkylation with Grignard Reagents
2008 StandoutNobel
Akt activation by estrogen in estrogen receptor-negative breast cancer cells.
2001
Detection of T cell responses to a ubiquitous cellular protein in autoimmune disease
2014 StandoutScienceNobel
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
2002 StandoutScience
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Vitamin B12: Experimente zur Frage nach dem Ursprung seiner molekularen Struktur
1988
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Constructing a molecular LEGO set
1992 StandoutNobel
Disulfonimide-Catalyzed Asymmetric Synthesis of β3-Amino Esters Directly from N-Boc-Amino Sulfones
2013 StandoutNobel
Diastereoselective microbial reduction of (S)-[3-chloro-2-oxo-1-(phenylmethyl)propyl]carbamic acid, 1,1-dimethylethyl ester
2003
Ketone-Catalyzed Asymmetric Epoxidation Reactions
2004
The Halogen Bond
2016 Standout
Design and Structure−Activity Relationship of a New Class of Potent VEGF Receptor Tyrosine Kinase Inhibitors
1999
Fluorine in medicinal chemistry: A review of anti-cancer agents
2006
Clinical Proteomics: From Biomarker Discovery and Cell Signaling Profiles to Individualized Personal Therapy
2005
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Chemistry of potentially prebiological natural products
1992
Stereoregular Oligomerization by Repetitive Diels–Alder Reactions
1989
The state of the art in asymmetric induction: the aldol reaction as a case study
2009
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling
2005 StandoutScience
Organocatalytic Oxidation. Asymmetric Epoxidation of Olefins Catalyzed by Chiral Ketones and Iminium Salts
2008
Enantioselective syntheses with titanium carbohydrate complexes. Part 7. Enantioselective allyltitanation of aldehydes with cyclopentadienyldialkoxyallyltitanium complexes
1992
Lewis Acid Catalyzed Asymmetric Cyanohydrin Synthesis
2008
Simultaneous Blockade of Platelet-Derived Growth Factor-Receptor and Epidermal Growth Factor-Receptor Signaling and Systemic Administration of Paclitaxel as Therapy for Human Prostate Cancer Metastasis in Bone of Nude Mice
2004
Organische Synthese — wohin?
1990
Molecular Self-Assembly and Nanochemistry: a Chemical Strategy for the Synthesis of Nanostructures
1991 StandoutScience
Structure‐Directed Synthesis of new organic materials
1989 StandoutNobel
Works of Guido Bold being referenced
Advances in the structural biology, design and clinical development of VEGF-R kinase inhibitors for the treatment of angiogenesis
2003
Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor
2008
Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase Inhibitors
2002
Tyrosine kinase inhibitors: From rational design to clinical trials
2001
A General Strategy for Targeting Drugs to Bone
2015
The preparation of chiral titanium reagents: a comparison of new and known ligands
1994
The Total Synthesis and Biological Assessment of trans-Epothilone A
2002
Enantioselective Synthesis of D ‐threo‐β‐Hydroxy‐α‐amino Acids with Titanium‐Carbohydrate Complexes
1989
A concise synthesis of aza-dipeptide isosteres
1998
CGP 53437, an orally bioavailable inhibitor of human immunodeficiency virus type 1 protease with potent antiviral activity
1993
Chemie der α‐Aminonitrile 1. Mitteilung Einleitung und Wege zu Uroporphyrinogen‐octanitrilen
1987
Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines
1997
A chiral bicyclic intermediate for the synthesis of forskolin
1987
Enantioselektive Synthese von D ‐threo‐β‐Hydroxy‐α‐aminosäuren mit Titan‐Kohlenhydrat‐Komplexen
1989
Herstellung von ‘Semialdehyd’‐Derivaten von Asparaginsäure‐ und Glutaminsäure durch Rosenmund‐Reduktion
1990
Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability
1996
Epothilones and Their Analogs – Potential New Weapons in the Fight Against Cancer
2000